ArticleBMC infectious diseases2022

SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.

Alexandra Dopfer-Jablonka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.